JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
  会員専用ページ

トップページ
学会案内
沿革
定款
役員・委員会
名誉会員・評議員
学術集会
総会学術集会
歴代総会・学術集会
支部・学術集会
学会教育研修会
国際関連学会
認定制度
リウマチ専門医
リウマチ指導医
教育施設
学会出版物
学会誌MR
NLリウマチ
リウマチ学用語集
会員手続き
本サイトについて
よくある質問
関連リンク集
サイトマップ
プライバシー
CASE REPORT

A case of pure red cell aplasia complicated by Evans syndrome

Authors

Yasuhiko Toyokawa1,2, Isamu Kingetsu1, Chiho Yasuda1, Jun Yasuda1, Ken Yoshida1, Daitaro Kurosaka1 and Akio Yamada1

  1. Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan
  2. Present address: Toyokawa Clinic, 3-22-12 Kotesashi-cho, Tokorozawa 359-1141, Japan
Received:

06 December 2006

Accepted:

05 March 2007

Full Text

Download (PDF) (member's only)

Abstract

A 33-year-old woman complaining of severe anemia was admitted to our hospital for polyclonal hyperglobulinemia. She was diagnosed with pure red cell aplasia (PRCA) associated with Evans syndrome. Initially, the presence of human parvovirus B19 (HPV B19) IgM appeared to indicate that the cause of PRCA was HPV B19 infection. Evans syndrome improved with steroid therapy, but PRCA was refractory. Cyclosporine was administered; consequently, the patient markedly recovered from PRCA and was discharged. PRCA complicated by Evans syndrome occurred during the course of polyclonal hyperglobulinemia. The most direct etiology for the onset of PRCA was unclear; however, immunological disorders such as polyclonal hyperglobulinemia, in addition to HPV B19 infection, may have been partly responsible for the etiology of PRCA.

Key words

Cyclosporine - Evans syndrome - Human parvovirus B19 - Polyclonal hyperglobulinemia - Pure red cell aplasia


Copyright Japan College of Rheumatology All rights reserved.